Karin Schulze

Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared to the licensed 3-dose schedule

Barbara Romanowski, Tino F. Schwarz, Linda M. Ferguson et al. · Human Vaccines · 2011 · 194 citations · Full text

Veterinary Medicine, Immunology, Oncology +13

Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination

Barbara Romanowski, Tino F. Schwarz, Linda M. Ferguson et al. · Human Vaccines & Immunotherapeutics · 2014 · 99 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Sustained immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent girls: Five-year clinical data and modeling predictions from a randomized study

Barbara Romanowski, Tino F. Schwarz, Linda Ferguson et al. · Human Vaccines & Immunotherapeutics · 2015 · 95 citations · Full text

Veterinary Medicine, Immunology, Pediatrics +17

Persistence of immune response to HPV-16/18 AS04-adjuvanted cervical cancer vaccine in women aged 15-55 years

Tino F. Schwarz, Marek Spaczyński, Achim Schneider et al. · Human Vaccines · 2011 · 42 citations · Full text

Veterinary Medicine, Immunology, Oncology +17

Persistence of immune responses to the <scp>HPV</scp>‐16/18 <scp>AS</scp>04‐adjuvanted vaccine in women aged 15–55 years and first‐time modelling of antibody responses in mature women: results from an open‐label 6–year follow‐up study

Tino F. Schwarz, Marek Spaczyński, Andreas M. Kaufmann et al. · BJOG An International Journal of Obstetrics & Gynaecology · 2014 · 41 citations · Full text

Veterinary Medicine, Gynecology, Immunology +17